Deletion of Nrip1 delays skin aging by reducing adipose-derived mesenchymal stem cells (ADMSCs) senescence, and maintaining ADMSCs quiescence

Yu Hu,Yun Zhu,Skyler D. Gerber,Jared M. Osland,Min Chen,Krishna A. Rao,Heng Gu,Rong Yuan
DOI: https://doi.org/10.1007/s11357-021-00344-y
2021-03-11
GeroScience
Abstract:Our previous studies found that deletion of nuclear receptor interacting protein 1 (<i>Nrip1</i>) extended longevity in female mice and delayed cell senescence. The current study investigates the role of NRIP1 in regulating functions of adipose-derived mesenchymal stem cells (ADMSCs) and explores the mechanisms of NRIP1 in skin aging. We first verified the skin aging phenotypes in young (6 months) and old (20 months) C57BL/6J (B6) mice and found deletion of <i>Nrip1</i> can delay skin aging phenotypes, including reduced thickness of dermis and subcutaneous white adipose tissue (sWAT), as well as the accumulation of senescent cells in sWAT. In ADMSCs isolated from sWAT, we found that deletion of <i>Nrip1</i> could decrease cell proliferation, prevent cell apoptosis, and suppress adipogenesis. Interestingly, deletion of <i>Nrip1</i> also reduced cell senescence and maintain cell quiescence of ADMSCs. Moreover, the expressions of genes associated with senescence (<i>p21</i>, and <i>p53</i>), inflammation (<i>p65</i>, <i>IL6</i>, and <i>IL1a</i>), and growth factor (<i>mTOR</i>, <i>Igf1</i>) were reduced in <i>Nrip1</i> knockout ADMSCs, as well as in <i>siNrip1</i>-treated ADMSCs. Suppression of <i>Nrip1</i> by <i>siNrip1</i> also decreased the expressions of mTOR, p-mTOR, p65, and p-p65 in ADMSCs. Reduced expressions of p65 and p-p65 were also confirmed in the skin of <i>Nrip1</i> knockout mice. These findings suggest that NRIP1 plays an important role in delaying skin aging by reducing ADMSCs senescence and maintaining ADMSCs quiescence.
geriatrics & gerontology,gerontology
What problem does this paper attempt to address?